Jude Byrne

1.3k total citations
18 papers, 466 citations indexed

About

Jude Byrne is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jude Byrne has authored 18 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Jude Byrne's work include HIV, Drug Use, Sexual Risk (9 papers), Hepatitis C virus research (7 papers) and Opioid Use Disorder Treatment (5 papers). Jude Byrne is often cited by papers focused on HIV, Drug Use, Sexual Risk (9 papers), Hepatitis C virus research (7 papers) and Opioid Use Disorder Treatment (5 papers). Jude Byrne collaborates with scholars based in Australia, United States and United Kingdom. Jude Byrne's co-authors include Jason Grebely, Tracy Swan, Andrew R. Lloyd, Julie Bruneau, Margaret Hellard, Philip Bruggmann, Alain H. Litwin, Olav Dalgård, Matthew Hickman and Gregory J. Dore and has published in prestigious journals such as Liver International, International Journal of Drug Policy and Drug and Alcohol Review.

In The Last Decade

Jude Byrne

15 papers receiving 456 citations

Peers

Jude Byrne

EPIDE

HEPAT

GHP

PHEOH

Jennifer V. Campbell United States

Jamee Newland Australia

Alya Briceño United States

Russell Rockwell United States

James P. McGough United States

Maggie Telfer United Kingdom

K. Li Canada

Carole Morissette Canada

Julian Surey United Kingdom

Rahul Hamid United States

Jennifer V. Campbell United States

Jude Byrne

533 ×1.4

EPIDE

363 ×1.3

HEPAT

74 ×0.8

GHP

188 ×2.2

75 ×1.1

PHEOH

Citations per year, relative to Jude Byrne Jude Byrne (= 1×) peers Jennifer V. Campbell

Countries citing papers authored by Jude Byrne

Since Specialization

Citations

This map shows the geographic impact of Jude Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jude Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jude Byrne more than expected).

Fields of papers citing papers by Jude Byrne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jude Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jude Byrne. The network helps show where Jude Byrne may publish in the future.

Co-authorship network of co-authors of Jude Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Jude Byrne. A scholar is included among the top collaborators of Jude Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jude Byrne. Jude Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sutherland, Rachel, et al.. (2023). Information acquisition and dissemination among a sample of people who inject drugs in Australia. Drug and Alcohol Review. 43(5). 1104–1111.

Nielsen, Suzanne, Anh Tran, Thomas Santo, et al.. (2022). Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients. Drug and Alcohol Review. 41(4). 841–850. 8 indexed citations

Brener, Loren, Timothy R. Broady, Elena Cama, et al.. (2021). Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs. International Journal of Drug Policy. 97. 103323–103323. 17 indexed citations

Higgs, Peter, et al.. (2020). Highlighting the palliative care needs of people using drugs. Collegian Journal of the Royal College of Nursing Australia. 27(5). 581–582.

Brown, Graham, Jude Byrne, Sione Crawford, et al.. (2019). Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination. International Journal of Drug Policy. 72. 24–32. 11 indexed citations

Brown, Graham, et al.. (2019). Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership. Harm Reduction Journal. 16(1). 37–37. 46 indexed citations

Hellard, Margaret, Carla Treloar, Julie Bruneau, et al.. (2018). Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver International. 39(1). 20–30. 83 indexed citations

Wolfe, Daniel, et al.. (2015). Human rights and access to hepatitis C treatment for people who inject drugs. International Journal of Drug Policy. 26(11). 1072–1080. 43 indexed citations

Marshall, Alison D., Michelle Micallef, Joanne Telenta, et al.. (2015). Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study. International Journal of Drug Policy. 26(10). 984–991. 39 indexed citations

10.

Grebely, Jason, Geert Robaeys, Philip Bruggmann, et al.. (2015). Recommendations for the management of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy. 26(10). 1028–1038. 135 indexed citations

11.

Grebely, Jason, Geert Robaeys, Philip Bruggmann, et al.. (2015). Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral. International Journal of Drug Policy. 111. 101671–101671.

12.

Iversen, Jenny, et al.. (2010). Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia. Drug and Alcohol Review. 29(4). 413–419. 8 indexed citations

13.

Byrne, Jude, et al.. (2009). Coexisting or conjoined: The growth of the international drug users’ movement through participation with International Harm Reduction Association Conferences. International Journal of Drug Policy. 21(2). 110–111. 6 indexed citations

14.

Dwyer, Robyn, et al.. (2002). ABRIDUS: The Australian Blood-borne Virus Risk and Injecting Drug Use Study: A study of hepatitis C risk practices and contexts in Melbourne, Perth and Sydney. 2 indexed citations

15.

Friedman, Samuel R., et al.. (2001). Harm reduction — a historical view from the left. International Journal of Drug Policy. 12(1). 3–14. 31 indexed citations

16.

Friedman, Samuel R., et al.. (2001). Harm reduction—a historical view from the left: a response to commentaries. International Journal of Drug Policy. 12(3). 259–263. 14 indexed citations

17.

Hanson, Ralph, et al.. (1992). Immunization status of Casualty attenders: Risk factors for non‐compliance and attitudes to ‘on the spot’ immunization. Journal of Paediatrics and Child Health. 28(6). 451–454. 22 indexed citations

18.

McWilliams, J. C. & Jude Byrne. (1951). Averages in rainfall for stations in Ireland 1916-1950. Trinity's Access to Research Output (TARA) (Trinity College Dublin). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact